Key Takeaways on Managing ABSSSI
George Sakoulas, MD, shares key takeaways on soft tissue infections from ID week 2023.
Antimicrobial Stewardship for ABSSSI Single-Dose Agents
Dr George Sakoulas provides insight on how single-dose agents fit into antimicrobial stewardship for soft tissue infections.
Expert Guidance on Managing Acute Bacterial Skin and Skin Structure Infections (ABSSSI) in an Outpatient Setting
George Sakoulas, MD, provides key insights on the management of soft tissue infections including the role of single-dose agents and treating patients in an outpatient setting.
Tailoring Therapies in Community Acquired Pneumonia in the Inpatient Setting
An expert in infectious diseases shares treatment considerations and clinical strategies for the management of community acquired pneumonia (CAP).
Unmet Needs and Key Takeaways in CAP Management
George Sakoulas, MD, highlights persistent unmet needs in managing CAP and key takeways from ID week 2023.
Understanding Multidrug-Resistant Pathogens (MDR) and Antimicrobial Stewardship in CAP
An expert in infectious diseases comments on multidrug-resistant pathogens such as pneumococcus in CAP, and shares thoughts on balancing antimicrobial stewardship with the pharmacoeconomics of antimicrobial therapies in CAP.
Current Therapies and Treatment Approaches for ABSSSI
An expert in infectious diseases reviews currently available therapeutic options for inpatient and outpatient treatment of ABSSSI and examines the advantages of using single-dose agents in patients.
Overview of Acute Bacterial Skin and Skin Structure Infections (ABSSSI)
George Sakoulas, MD, provides an overview of the burden of acute bacterial skin and skin structure infections (ABSSSI) and patient selection for treatment in the outpatient setting.
Strategies for Approaching Treatment Selection of CAP
Dr George Sakoulas shares strategies for selecting single and combination therapy when dealing with empiric vs focused treatment regimens for CAP and discusses clinical considerations for elderly patients hospitalized with CAP.
Burden of Community Acquired Pneumonia (CAP)
George Sakoulas, MD, provides insight on the burden on the healthcare community of community acquired pneumonia (CAP) and the influence of geography and seasonal variations on CAP.
Synergy Between Antibiotics and The Innate Immune System
Growing evidence suggests that antimicrobials also interact with host innate immunity to provide potent indirect effects which enhance bacterial clearance and may result in more rapid and complete effects
Transitioning From Adequate to Optimal Therapy in Staphylococcus aureus Bacteremia
Therapy options have increased in recent decades, yet there is a lack of guidance.
2 Clarke Drive Cranbury, NJ 08512